University–pharmacy partnerships for COVID-19

doi:10.1126/science.abe3339

GSTDTAP > 气候变化

DOI	10.1126/science.abe3339
	University–pharmacy partnerships for COVID-19
	Vincent J. Venditto; Brooke Hudspeth; Patricia R. Freeman; Clark Kebodeaux; R. Kiplin Guy
	2020-09-18
发表期刊	Science
出版年	2020
英文摘要	The global coronavirus disease 2019 (COVID-19) pandemic has accelerated epidemiologic data collection and reporting to a scale that has never before been achieved ([ 1 ][1]). Both data volume and segmentation have grown enormously, with granularity of data to track infection now available at the county level or below ([ 2 ][2]). Years of disinvestment in U.S. public health infrastructure ([ 3 ][3]) have resulted in the immediate need for new mechanisms to support micro-epidemiologic efforts. Universities and community pharmacies, both trusted institutions with established infrastructure, are uniquely positioned to facilitate micro-epidemiologic efforts by creating partnerships ([ 4 ][4]). Micro-epidemiology has been used to track the spatial and temporal prevalence of infection in distinct communities ([ 5 ][5]). Coupled with longitudinal testing, microepidemiology serves as a sentinel for viral emergence and evolution ([ 6 ][6]), which can be applied to the COVID-19 pandemic. Harnessing the established infrastructure of community pharmacies enables coordination of appropriate testing, tracing, and isolation in these communities. Ninety percent of U.S. residents live within 5 miles of a pharmacy, and in some underserved communities, pharmacists are the only health care provider ([ 7 ][7]). Community pharmacists are pillars of their communities with trusted connections with patients ([ 4 ][4]). Pharmacists are trained and authorized to order and administer COVID-19 testing ([ 8 ][8]) and have widespread authority to administer vaccinations ([ 9 ][9]). In addition, increasing numbers of pharmacists are participating in practice-based research networks (PBRNs) ([ 10 ][10]), which are designed to improve community-based health care by providing higher-quality chronic disease management. University–community pharmacy partnerships follow the PBRN paradigm and harness the strengths of both institutions. Community pharmacies provide a geographically distributed network of accessible health care professionals and can serve as nodes for patient recruitment, whereas the university serves as a logistical and research hub to provide testing, reporting, contact tracing, educational resources, and the research infrastructure required to facilitate such studies. The University can also provide research personnel capable of managing these efforts, allowing the pharmacists to prioritize patient care. The U.S. Centers for Disease Control and Prevention has recommended that health departments leverage community pharmacy partnerships to improve public health emergency response ([ 11 ][11], [ 12 ][12]). We call on schools of pharmacy and public health to forge new relationships and leverage existing partnerships with community pharmacies to meet the current critical need to understand and mitigate COVID-19 and prepare for future pandemic response. 1. [↵][13]1. D. A. Drew et al ., Science 368, 1362 (2020). [OpenUrl][14][Abstract/FREE Full Text][15] 2. [↵][16]1. A. Mollalo, 2. B. Vahedi, 3. K. M. Rivera , Sci. Tot. Environ. 728, 138884 (2020). [OpenUrl][17] 3. [↵][18]1. D. U. Himmelstein, 2. S. Woolhandler , Am. J. Public Health 106, 56 (2016). [OpenUrl][19] 4. [↵][20]1. J. V. Goode, 2. D. A. Mott, 3. R. Chater , J. Am. Pharm. Assoc. 48, 153 (2008). [OpenUrl][21][CrossRef][22] 5. [↵][23]1. C. S. Nelson et al ., Nat. Commun. 10, 5615 (2019). [OpenUrl][24] 6. [↵][25]1. P. Mogeni et al ., BMC Med. 15, 121 (2017). [OpenUrl][26][CrossRef][27] 7. [↵][28]National Association of Chain Drug Stores, “Pharmacies: A vital partner in reopening America” (2020). 8. [↵][29]U.S. Department of Health and Human Services, “Guidance for licensed pharmacists, COVID-19 testing, and immunity under the PREP Act” (2020). 9. [↵][30]1. S. M. Bartsch et al ., Vaccine 36, 7054 (2018). [OpenUrl][31] 10. [↵][32]1. J.-V. R. Goode et al ., J. Am. Pharm. Assoc. 48, 153 (2008). [OpenUrl][21][CrossRef][22] 11. [↵][33]1. S. E. Rubin et al ., Biosecur. Bioterror. 12, 76 (2014). [OpenUrl][34] 12. [↵][35]1. L. M. Koonin et al ., Disaster Med. Public Health Prep. 5, 253 (2011). [OpenUrl][36][CrossRef][37][PubMed][38] [1]: #ref-1 [2]: #ref-2 [3]: #ref-3 [4]: #ref-4 [5]: #ref-5 [6]: #ref-6 [7]: #ref-7 [8]: #ref-8 [9]: #ref-9 [10]: #ref-10 [11]: #ref-11 [12]: #ref-12 [13]: #xref-ref-1-1 "View reference 1 in text" [14]: {openurl}?query=rft.jtitle%253DScience%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.abc0473%26rft_id%253Dinfo%253Apmid%252F32371477%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [15]: /lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEzOiIzNjgvNjQ5Ny8xMzYyIjtzOjQ6ImF0b20iO3M6MjM6Ii9zY2kvMzY5LzY1MTAvMTQ0MS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30= [16]: #xref-ref-2-1 "View reference 2 in text" [17]: {openurl}?query=rft.jtitle%253DSci.%2BTot.%2BEnviron.%26rft.volume%253D728%26rft.spage%253D138884%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [18]: #xref-ref-3-1 "View reference 3 in text" [19]: {openurl}?query=rft.jtitle%253DAm.%2BJ.%2BPublic%2BHealth%26rft.volume%253D106%26rft.spage%253D56%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [20]: #xref-ref-4-1 "View reference 4 in text" [21]: {openurl}?query=rft.jtitle%253DJ.%2BAm.%2BPharm.%2BAssoc.%26rft.volume%253D48%26rft.spage%253D153%26rft_id%253Dinfo%253Adoi%252F10.1331%252FJAPhA.2008.07139%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [22]: /lookup/external-ref?access_num=10.1331/JAPhA.2008.07139&link_type=DOI [23]: #xref-ref-5-1 "View reference 5 in text" [24]: {openurl}?query=rft.jtitle%253DNat.%2BCommun.%26rft.volume%253D10%26rft.spage%253D5615%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [25]: #xref-ref-6-1 "View reference 6 in text" [26]: {openurl}?query=rft.jtitle%253DBMC%2BMed.%26rft.volume%253D15%26rft.spage%253D121%26rft_id%253Dinfo%253Adoi%252F10.1186%252Fs12916-017-0887-4%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [27]: /lookup/external-ref?access_num=10.1186/s12916-017-0887-4&link_type=DOI [28]: #xref-ref-7-1 "View reference 7 in text" [29]: #xref-ref-8-1 "View reference 8 in text" [30]: #xref-ref-9-1 "View reference 9 in text" [31]: {openurl}?query=rft.jtitle%253DVaccine%26rft.volume%253D36%26rft.spage%253D7054%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [32]: #xref-ref-10-1 "View reference 10 in text" [33]: #xref-ref-11-1 "View reference 11 in text" [34]: {openurl}?query=rft.jtitle%253DBiosecur.%2BBioterror.%26rft.volume%253D12%26rft.spage%253D76%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [35]: #xref-ref-12-1 "View reference 12 in text" [36]: {openurl}?query=rft.jtitle%253DDisaster%2BMedicine%2Band%2BPublic%2BHealth%2BPreparedness%26rft.stitle%253Ddmphp%26rft.aulast%253DKoonin%26rft.auinit1%253DL.%2BM.%26rft.volume%253D5%26rft.issue%253D4%26rft.spage%253D253%26rft.epage%253D255%26rft.atitle%253DCDC%2527s%2B2009%2BH1N1%2BVaccine%2BPharmacy%2BInitiative%2Bin%2Bthe%2BUnited%2BStates%253A%2BImplications%2Bfor%2BFuture%2BPublic%2BHealth%2Band%2BPharmacy%2BCollaborations%2Bfor%2BEmergency%2BResponse%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fdmp.2011.83%26rft_id%253Dinfo%253Apmid%252F22146661%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [37]: /lookup/external-ref?access_num=10.1001/dmp.2011.83&link_type=DOI [38]: /lookup/external-ref?access_num=22146661&link_type=MED&atom=%2Fsci%2F369%2F6510%2F1441.atom
领域	气候变化 ; 资源环境
URL	查看原文
引用统计
文献类型	期刊论文
条目标识符	http://119.78.100.173/C666/handle/2XK7JSWQ/295406
专题	气候变化资源环境科学
推荐引用方式 GB/T 7714	Vincent J. Venditto,Brooke Hudspeth,Patricia R. Freeman,等. University–pharmacy partnerships for COVID-19[J]. Science,2020.
APA	Vincent J. Venditto,Brooke Hudspeth,Patricia R. Freeman,Clark Kebodeaux,&R. Kiplin Guy.(2020).University–pharmacy partnerships for COVID-19.Science.
MLA	Vincent J. Venditto,et al."University–pharmacy partnerships for COVID-19".Science (2020).